World Health Organization Redefines Burnout As An “Occupational Phenomenon”

CBS News (5/28, Ivanova) reports on its website that the World Health Organization “now includes ‘burnout’ in its International Classification of Diseases Handbook, where it is described as an occupational-related condition ‘resulting from chronic workplace stress that has not been successfully managed.’” The story explains that “according to the WHO, doctors can issue a diagnosis of burnout if a patient exhibits three symptoms: feeling depleted of energy or exhausted; feeling mentally distanced from or cynical about one’s job; and problems getting one’s job done successfully,” although “burnout is to be used specifically ‘in the occupational context’ and that it ‘should not be applied to describe experiences in other areas of life.’”

NPR (5/28, Wroth) reports that “despite earlier reports to the contrary, WHO does not classify the problem as a medical condition” but instead “calls burnout an ‘occupational phenomenon’ and includes it in a chapter on ‘factors influencing health status or contact with health services.’”

Study Shows Physician Burnout Costs Approximately $4.6 Billion Each Year TIME (5/28, Oaklander) reports that US physicians “experience symptoms of burnout at almost twice the rate of other workers, often citing as contributors the long hours, a fear of being sued, and having to deal with growing bureaucracy, like filling out clunky and time-consuming electronic medical records.” Now, TIME writes, “the economic impacts of burnout are also significant, costing the U.S. some $4.6 billion every year, according to a new study published in the journal Annals of Internal Medicine.”

HealthDay (5/28, Reinberg) reports that for this study, lead researcher Joel Goh from the National University of Singapore “and a team of researchers from Stanford University, the Mayo Clinic, and the American Medical Association created a mathematical model to estimate the cost of doctor turnover and the shorter hours that result from burnout.” Goh said, “We found that at an organizational level, the annual burnout-associated cost was estimated at approximately $7,600 per physician per year. At a national level, the estimated cost ranged from $3 billion to $6 billion a year.”

Related Links:

— “World Health Organization classifies work “burnout” as an occupational phenomenon, “Irina Ivanova, CBS News, May 28, 2019

Participation In Team Sports As A Young Person May Significantly Reduce Likelihood Of Depression, Anxiety For People With Childhood Trauma, Study Indicates

The NPR (5/28, Neilson) “Shots” blog reports, “Participation in team sports as a young person can significantly reduce the long-term likelihood of depression and anxiety for people with childhood trauma,” researchers concluded after analyzing “data from 9668 teens who participated in the National Longitudinal Study of Adolescent to Adult Health.” The findings were published online May 28 in JAMA Pediatrics.

MedPage Today (5/28, Hlavinka) reports the authors of an accompanying editorial wrote, “The wins and losses of sports teach the emotional dexterity required for success in life, including resilience.” They added, “These beneficial characteristics of sport participation may lead to better mental and social health and academic success and may lower the likelihood of participating in risky behaviors.”

Related Links:

— “Playing Teen Sports May Protect From Some Damages Of Childhood Trauma, “Susie Neilson, NPR, May 28, 2019

Prescription Stimulant Abuse In Youth Once Again On The Increase, Research Indicates

Medscape (5/28, Anderson, Subscription Publication) reports, “After a lull in the rates of prescription stimulant abuse in youth, it looks as though the phenomenon is on the rise again,” researchers concluded after analyzing survey responses “from 1777 respondents ages 10 to 17 years.” Specifically, data from “the Study of Non-Oral Administration of Prescription Stimulants (SNAPS) found that almost 14% of young respondents who used a prescription stimulant had snorted, smoked, or injected” the medication. The findings were presented at the American Psychiatric Association’s annual meeting.

Related Links:

— “Prescription Stimulant Abuse in Youth Rising… Again, “Pauline Anderson, Medscape, May 28, 2019

WHO Removes “Gender Identity Disorder” From List Of Mental Illnesses

On its website, CBS News (5/28, Lewis) reports the World Health Organization (WHO) announced it will remove “gender identity disorder” from the revised version of the International Classification of Diseases (ICD), “its global manual of diagnoses.” The change, announced last summer, includes “a resolution to amend the health guidelines” officially approved on Saturday and reclassifies “gender identity disorder” as “gender incongruence.” That classification “is now featured under the sexual health chapter rather than the mental disorders chapter.” The piece adds that “both the ICD and the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) are used to diagnose patients,” and the American Psychiatric Association “last revised the DSM in 2012 to remove the term ‘gender identity disorder’ from the manual and add the term ‘gender dysphoria.’”

The New York Daily News (5/28, Assunção) reports the changes received approval Saturday at the World Health Assembly. Graeme Reid, LGBT rights director at Human Rights Watch, said, “The WHO’s removal of ‘gender identity disorder’ from its diagnostic manual will have a liberating effect on transgender people worldwide,” adding, “Governments should swiftly reform national medical systems and laws that require this now officially outdated diagnosis.” Dr. Jack Drescher, a member of the ICD-11 working group, wrote, “there is substantial evidence that the stigma associated with the intersection of transgender status and mental disorders contributes to precarious legal status [and] human rights violations.”

TIME (5/28, Haynes) and the Washington Examiner (5/28, Correll) also report.

Related Links:

— “World Health Organization removes “gender identity disorder” from list of mental illnesses, “Sophie Lewis, CBS News, May 28, 2019

FDA To Hold Hearing On CBD Product Regulation

Bloomberg (5/27, Owram) reports that “the U.S. Food and Drug Administration will hold its first public hearing Friday into how it should regulate CBD products, and it may end up limiting how much of the cannabis compound can be included in food and drinks.” There is currently “pressure on the FDA to act quickly” in deciding how to regulate CBD products, “but the agency has expressed concern that allowing the substance in food, beverages and supplements will lessen the incentive for pharmaceutical companies to conduct clinical research into the health benefits of CBD.” The piece adds that “in announcing the May 31 hearings, then-FDA Commissioner Scott Gottlieb said in a statement that there are ‘open questions about whether some threshold level of CBD could be allowed in foods without undermining the drug approval process or diminishing commercial incentives for further clinical study of the relevant drug substance.’”

Related Links:

— “U.S. Reviews CBD Amid Pressure to Act Quickly, ” Kristine Owram, Bloomberg, May 27, 2019

Opioid Overdose, Associated Mortality Rates Appear To Have Increased Among Veterans From 2010-2016, Research Suggests

MD Magazine (5/27, Genn) reported researchers from “the Veterans Health Administration (VHA) found that opioid overdose and associated mortality rates increased among veterans from 2010-2016.” Included in the study were any veterans “who had at least one VHA inpatient or outpatient interaction during the year of their death or preceding year.” For the study, “forms of overdose deaths were categorized by the Centers for Disease Control and Prevention (CDC) death codes, while the tenth revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) defined forms of opioids associated with veteran deaths.” The findings (pdf) were published online in the American Journal of Preventive Medicine.

Related Links:

— “Veteran Opioid Overdose Deaths Are on the Rise, “Laura Genn, MD Magazine, May 27, 2019

Long-Term Opioid Use Among Parents May Increase Odds Of Their Children Attempting Suicide, Study Indicates

Reuters (5/22, Dobuzinskis) reports, “The U.S. opioid crisis is taking a toll on children of users as a” new study indicates “they were more likely to attempt suicide.”

U.S. News & World Report (5/22, Newman) reports investigators “caution parents’ long-term use of opioids may increase the odds of their kids attempting suicide.” Included in the health insurance claims data analysis were “184,142 children who had parents that used opioids and 148,395 children whose parents did not.” The study revealed that “children whose parents had used opioids long-term had a risk of 3.68 per 1,000 of attempting suicide – 2.25 times the risk of suicidal behavior for those whose parents had not filled their prescriptions.” The findings were published online May 22 in JAMA Psychiatry. HealthDay (5/22, Preidt) also covers the study.

Related Links:

— “Children of opioid users more likely to attempt suicide: U.S. study, “Alex Dobuzinskis, Reuters, May 22, 2019

People With Bipolar Disorder May Have Higher Risk For Parkinson’s Disease, Study Indicates

MedPage Today (5/22, George) reports researchers found in a longitudinal study that “people with bipolar disorder had a higher risk of Parkinson’s disease than people without the disorder.” The findings were of the 56,340-adult study were published online May 22 in Neurology. The authors of an accompanying editorialobserved that the study’s results should be interpreted with the understanding that it’s difficult to determine when Parkinson’s disease starts, and as such it’s possible that “bipolar disorder or mood dysregulation approximating bipolar disorder may more appropriately be viewed as an early symptom of Parkinson’s disease.”

Related Links:

— “Parkinson’s Tied to Bipolar Disorder, “Judy George, MedPage Today, May 22, 2019

Many Patients With MDD And Suicidal Ideation Or Suicidal Attempt Diagnosed In ED Or Hospital May Experience Readmission Or Future ED Visit Within Six Months Following Discharge, Studies Indicate

Healio (5/21, Adams) reports, “Data from three studies presented” at the American Psychiatric Association’s annual meeting indicated that “among patients with major depressive disorder [MDD] and suicidal ideation or suicide attempt who were diagnosed during hospitalization or visit to the” emergency department (ED), “8.4% experienced readmission or a future ED visit within six months after discharge.” In addition, “researchers reported that treatment within the year prior to suicidal ideation was distinctly low among these patients.”

Related Links:

— “Studies highlight unmet needs in patients with MDD, suicide attempt/ideation, “Ella Daly, MD, Healio, May 21, 2019

New Teen Drivers With AD/HD More Likely To Crash Than Teens Who Do Not Have The Disorder, Research Indicates

Reuters (5/20, Rapaport) reports, “New teen drivers with” attention-deficit/hyperactivity disorder (AD/HD) “are more likely to crash their cars than adolescents who don’t have” the disorder, particularly “right after they get their license,” researchers concluded after following “14,936 teens in New Jersey for two years.” When compared to teenagers without AD/HD, “young drivers with the condition were 62 percent more likely to crash within the first month of getting licensed, the study found.” What’s more, “over their first four years behind the wheel, teens with” AD/HD “were 37 percent more likely to crash,” the study revealed. The findings were published online in Pediatrics. HealthDay (5/20, Gordon) also covers the study.

Related Links:

— “Teen drivers with ADHD have higher crash rates even with graduated licenses, “Lisa Rapaport, Reuters, May 20, 2019